Clinical Trial Update: The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy and safety of DWP14012 in Chinese patients with reflux esophagitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reflux Esophagitis

Drugs mentioned

• DWP14012

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Reflux Esophagitis | Phase 3 | Status: COMPLETED